Table 1. Demographic and clinical characteristics.
| Variables | |
|---|---|
| Mean (SD) age, years | 15.8 (1.8) |
| Sex | |
| Male, N (%) | 60 (40) |
| Female, N (%) | 91 (60) |
| Race/ethnicity | |
| White (not Hispanic), N (%) | 13 (9) |
| Black/African-American (not Hispanic), N (%) | 129 (85) |
| Asian or Pacific Islander, N (%) | 1 (1) |
| Native American or Alaskan Native, N (%) | 1 (1) |
| Biracial, N (%) | 4 (3) |
| Other, N (%) | 3 (2) |
| Health insurance* | |
| None, N (%) | 26 (17) |
| Public, N (%) | 101 (66) |
| Private, N (%) | 20 (13) |
| Highest level of participant education† | |
| Grade 6–8, N (%) | 27 (18) |
| Grade 9–12, N (%) | 102 (68) |
| In GED program, N (%) | 6 (4) |
| In college, N (%) | 2 (1) |
| Not currently in school | 12 (8) |
| Home schooled | 1 (1) |
| Highest level of parental education‡ | |
| Did not finish high school, N (%) | 21 (14) |
| Graduated from high school or passed GED exam, N (%) | 44 (29) |
| Received some college education, N (%) | 42 (28) |
| Graduated from college, N (%) | 31 (21) |
| Graduate with an advanced degree, N (%) | 3 (2) |
| Not sure, N (%) | 9 (6) |
| Medications | |
| Inhaled corticosteroids, N (%) | 81 (51) |
| Oral corticosteroids, N (%) | 4 (3) |
| Inhaled beta-agonists, N (%) | 139 (98) |
| Other, N (%) | 10 (7) |
| Asthma severity§ | |
| Intermittent, N (%) | 72 (48) |
| Mild persistent, N (%) | 38 (25) |
| Moderate persistent, N (%) | 36 (24) |
| Severe persistent, N (%) | 5 (3) |
*
N = 147;
†
N = 150;
‡
The highest level of parental (mother or father) or caregiver education was used;
§
According to National Heart Lung and Blood Institute criteria
GED General Equivalency Diploma